Interstitial Plasmin Activity With Epsilon Aminocaproic Acid: Temporal and Regional Heterogeneity

Annals of Thoracic Surgery

Volumn 89, Issue 5, 2010, Pages 1538-1545

  Reust, Daryl L ^a   Reeves, Scott T ^a   Abernathy III, James H ^a   Dixon, Jennifer A ^a   Gaillard Jr , William F ^a   Mukherjee, Rupak ^a   Koval, Christine N ^a   Stroud, Robert E ^a   Spinale, Francis G ^a  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; PLASMIN; SODIUM CHLORIDE; ANTIFIBRINOLYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIALYSATE; ENZYME ACTIVITY; ENZYME POLYMORPHISM; EXPERIMENTAL PIG; FIBRINOLYSIS; FLUORESCENCE IMAGING; HEART MUSCLE; IN VIVO STUDY; KIDNEY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; VALIDATION STUDY; ANALYSIS OF VARIANCE; ANIMAL; AREA UNDER THE CURVE; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; HEART; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LIVER; METABOLISM; METHODOLOGY; PROBABILITY; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; SPECTROFLUOROMETRY; SWINE;

6-AMINOCAPROIC ACID; ANALYSIS OF VARIANCE; ANIMALS; ANTIFIBRINOLYTIC AGENTS; AREA UNDER CURVE; DISEASE MODELS, ANIMAL; FIBRINOLYSIN; FIBRINOLYSIS; HEART; INFUSIONS, INTRAVENOUS; KIDNEY; LIVER; MALE; MICRODIALYSIS; PROBABILITY; QUADRICEPS MUSCLE; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; SWINE;

EID: 77953042258     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.01.051     Document Type: Article

References (34)

1. Laupacis A., and Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anesth Analg 85 (1997) 1258-1267
2. Hardy J.F., and Bélisle S. Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency. Can J Anesth 41 (1994) 1104-1112
3. Ferraris V.A., Ferraris S.P., Saha S.P., et al., Society of Thoracic Surgeons Blood Conservation Guideline Task Force. Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83 Suppl (2007) 27-86
4. Fraser I.S., Porte R.J., Kouides P.A., and Lukes A.S. A benefit-risk review of systemic haemostatic agents. Part 1: in major surgery. Drug Safety 31 (2008) 217-230
5. Fergusson D.A., Hébert P.C., Mazer C.D., et al., BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008) 2319-2331
6. Kincaid E.H., Ashburn D.A., Hoyle J.R., Reichert M.G., Hammon J.W., and Kon N.D. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?. Ann Thorac Surg 80 (2005) 1388-1393
7. Mutter W.P., Stillman I.E., and Dahl N.K. Thrombotic microangiopathy and renal failure exacerbated by epsilon-aminocaproic acid. Am J Kidney Dis 53 (2009) 346-350
8. Wymenga L.F., and van der Boon W.J. Obstruction of the renal pelvis due to an insoluble blood clot after epsilon-aminocaproic acid therapy: resolution with intraureteral streptokinase instillations. J Urol 159 (1998) 490-492
9. Hocker J.R., and Saving K.L. Fatal aortic thrombosis in a neonate during infusion of epsilon-aminocaproic acid. J Pediatr Surg 30 (1995) 1490-1492
10. Dentz M.E., Slaughter T.F., and Mark J.B. Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid. Anesthesiology 82 (1995) 583-586
11. Hoffman E.P., and Koo A.H. Cerebral thrombosis associated with Amicar therapy. Radiology 131 (1979) 687-689
12. Seymour B.D., and Rubinger M. Rhabdomyolysis induced by epsilon-aminocaproic acid. Ann Pharmacother 31 (1997) 56-58
13. Hunt B.J., Parratt R.N., Segal H.C., Sheikh S., Kallis P., and Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg 65 (1998) 712-718
14. Duggan E., O'Dwyer M.J., Caraher E., et al. Coagulopathy after cardiac surgery may be influenced by a functional plasminogen activator inhibitor polymorphism. Anesth Analg 104 (2007) 1343-1347
15. Slaughter T.F., Faghih F., Greenberg C.S., Leslie J.B., and Sladen R.N. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg 85 (1997) 1221-1226
16. Shaw A., Swaminathan M., and Stafford-Smith M. Cardiac surgery-associated acute kidney injury: putting together the pieces of the puzzle. Nephron Physiol 109 (2008) 55-60
17. Mangano D.T., Tudor I.C., Dietzel C., and Multicenter Study of Perioperative Ischemia Research Group. Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
18. Mori T., Aisa Y., Shimizu T., et al. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation. Am J Hematol 82 (2007) 838-839
19. Stensrud P.E., and Nuttal G.A. Pharmacology of antifibrinolytic agents. Advance Cardiovasc Pharmacol 8 (2008) 183-204
20. Spinale F.G., Koval C.N., Deschamps A.M., Stroud R.E., and Ikonomidis J.S. Dynamic changes in matrix metalloproteinase activity within the human myocardial interstitium during myocardial arrest and reperfusion. Circulation 118 Suppl (2008) 16-23
21. Deschamps A.M., Zavadzkas J., Murphy R.L., et al. Interruption of endothelin signaling modifies membrane type 1 matrix metalloproteinase activity during ischemia and reperfusion. Am J Physiol Heart Circ Physiol 294 (2008) 875-883
22. Smith R.E., Bissell E.R., Mitchell A.R., and Pearson K.W. Direct photometric or fluorometric assay of proteinases using substrates containing 7-amino-4-trifluoromethylcoumarin. Thromb Res 17 (1980) 393-402
23. Nuttall G.A., Brost B.C., Connis R.T., et al. Practice guidelines for perioperative blood transfusion and adjuvant therapies. An updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies. Anesthesiology 105 (2006) 198-208
24. Marietta M., Facchini L., Pedrazzi P., Busani S., and Torelli G. Pathophysiology of bleeding in surgery. Transplant Proc 38 (2006) 812-814
25. Goodnough L.T. Risks of blood transfusion. Anesthesiol Clin North Am 23 (2005) 241-252
26. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 29 (1985) 236-261
27. Bennett-Guerrero E., Sorohan J.G., Canada A.T., et al. Epsilon-aminocaproic acid plasma levels during cardiopulmonary bypass. Anesth Analg 85 (1997) 248-251
28. Butterworth J., James R.L., Lin Y., Prielipp R.C., and Hudspeth A.S. Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery. Anesthesiology 90 (1999) 1624-1635
29. Ririe D.G., James R.L., O'Brien J.J., et al. The pharmacokinetics of epsilon-aminocaproic acid in children undergoing surgical repair of congenital heart defects. Anesth Analg 94 (2002) 44-49
30. Roelofs J.J., Rouschop K.M., Leemans J.C., et al. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol 17 (2006) 131-140
31. Dietrich W., Nicklisch S., Koster A., Spannagl M., Giersiefen H., and van de Locht A. CU-2010: a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties. Anesthesiology 110 (2009) 123-130
32. Nilsson I.M. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol 14 Suppl (1980) 41-47
33. McNicol G.P., Fletcher A.P., Alkjaersig N., and Sherry S. The absorption, distribution, and excretion of epsilon-aminocaproic acid following oral or intravenous administration to man. J Lab Clin Med 59 (1962) 15-24
34. Edmunds L.H. Managing fibrinolysis without aprotinin. Ann Thorac Surg 89 (2010) 324-331